SITC Archive Library

The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 115: Regulatory Subcommittee Session (Part 1)" during the 37^th Annual Meeting & Pre-Conference Programs on November 10, 2022. Available here are the presentation slides and video from the session, as permitted by presenters.

SESSION CO-CHAIRS

• Cecilia Yeung, MD – Fred Hutchinson Cancer Center
• Alessandra Cesano, MD – ESSA Pharma

Panelists

• Chantale Bernatchez, PhD – Cell Therapy Manufacturing Center
• Alessandra Cesano, MD – ESSA Pharma
• Lola Fashoyin-Aje, MD, MPH – US Food and Drug Administration
• Bindu Kanapuru, MD – US Food and Drug Administration
• Mike LeBlanc, PhD – Fred Hutchinson Cancer Center
• Mirat Shah, MD – US Food and Drug Administration
• Cecilia Yeung, MD – Fred Hutchinson Cancer Center

37^TH ANNUAL MEETING ORGANIZERS

ANNUAL PROGRAM COMMITTEE

The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.

To view the entire program schedule (including presenter permission to post) please click here.